Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

TripSitter Clinic Ltd (UY00) Stock Price & Analysis

UY00 Stock Chart & Stats

€0.09€0.00(0.00%)
At close: 1:00 AM GMT+1
€0.05€0.1€0.1526 Feb13 Mar16 Mar8 Apr4 May
Day’s Range
EUR 0.09 - EUR 0.09
52-Week Range
EUR 0.02 - EUR 0.15
Previous Close
EUR 0.09
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 2.12M
Enterprise Value
EUR 1.05M
Total Cash (Recent Filing)
EUR 598
Total Debt (Recent Filing)
EUR 389.11K
Price to Earnings (P/E)
―
Beta
1.09
Next Earnings
Dec 22, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Reduced Cash Burn

Free cash flow losses have materially narrowed versus the very large outflows in FY2022–FY2024. A smaller absolute cash burn improves runway and reduces near-term refinancing urgency, increasing the odds management can execute a restructuring or revenue restart over months.

Structural Industry Demand

Operating in healthcare information services provides durable structural demand as providers and systems continue to prioritize digital information and analytics. That underlying industry traction supports potential revenue recovery if product-market fit or sales execution improves.

Ongoing Disclosure Cadence

A scheduled next earnings release indicates continued public reporting and governance. Regular disclosure gives stakeholders timely visibility into operational progress, financing plans or restructuring steps, enabling clearer oversight and accountability during a multi-month recovery.

Bears Say

Revenue Collapse

Revenue near zero eliminates operating scale and renders gross margins and unit economics non-informative. With minimal sales, fixed costs and selling efforts cannot be absorbed, making sustainable profitability dependent on a material and durable revenue reboot or significant restructuring.

Negative Equity And Rising Debt

Deeply negative equity and rising debt are structural solvency concerns that constrain financing options and raise recapitalization risk. This weak capital base increases the likelihood of dilution or creditor-driven restructurings over the medium term, limiting strategic flexibility.

Persistent Negative Cash Flow

Ongoing negative operating and free cash flows mean the business remains dependent on external funding to sustain operations. Even with moderated outflows, persistent cash deficits elevate financing and execution risk and can force cutbacks or dilutive raises within several months if revenues don't resume.

TripSitter Clinic Ltd News

UY00 FAQ

What was TripSitter Clinic Ltd’s price range in the past 12 months?
TripSitter Clinic Ltd lowest stock price was €0.02 and its highest was €0.15 in the past 12 months.
What is TripSitter Clinic Ltd’s market cap?
TripSitter Clinic Ltd’s market cap is €2.12M.
When is TripSitter Clinic Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were TripSitter Clinic Ltd’s earnings last quarter?
TripSitter Clinic Ltd released its earnings results on Dec 23, 2025. The company reported -€0.002 earnings per share for the quarter.
Is TripSitter Clinic Ltd overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does TripSitter Clinic Ltd pay dividends?
TripSitter Clinic Ltd does not currently pay dividends.
What is TripSitter Clinic Ltd’s EPS estimate?
TripSitter Clinic Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TripSitter Clinic Ltd have?
TripSitter Clinic Ltd has 17,396,345 shares outstanding.
What happened to TripSitter Clinic Ltd’s price movement after its last earnings report?
TripSitter Clinic Ltd reported an EPS of -€0.002 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of TripSitter Clinic Ltd?
Currently, no hedge funds are holding shares in DE:UY00
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology